NASDAQ:FTXH First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News $28.65 -0.25 (-0.87%) (As of 01:17 PM ET) Add Compare Share Share Today's Range$28.65▼$28.6550-Day Range$26.75▼$29.6652-Week Range$23.85▼$29.72Volume417 shsAverage Volume5,899 shsMarket Capitalization$18.62 millionAssets Under Management$17.36 millionDividend Yield1.36%Net Expense Ratio0.60% Stock AnalysisStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get First Trust Nasdaq Pharmaceuticals ETF alerts: Email Address About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Read More FTXH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTXH ETF News HeadlinesAugust 3, 2022 | stocknews.com3 Health Care ETFs You'll Want to Own When the Market RecoversMay 25, 2022 | nasdaq.comSurprising Analyst 12-Month Target For FTXHSeptember 12, 2024 | Crypto 101 Media (Ad)Trillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…March 25, 2022 | seekingalpha.comFirst Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0488February 22, 2022 | nasdaq.comSolid Q4 Earnings Fail to Impress Pharma ETFsNovember 9, 2021 | nasdaq.comWave of Solid Q3 Earnings Push Pharma ETFs HigherAugust 19, 2021 | msn.com4 ETF Strategies to Follow Warren Buffett's VisionSee More Headlines Receive FTXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFirst Trust Fund NameFirst Trust Nasdaq Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FTXH Inception Date9/20/2016 Fund ManagerDaniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkNasdaq US Smart Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings51 Fund Statistics Assets Under Management$17.39 million Average Daily Volume$4,854.80 Discount/Premium-0.03% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest300 shs Miscellaneous Outstanding Shares650,000Beta0.70 Creation Unit50,000 Creation Fee$500.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Ad Crypto 101 MediaTrillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW First Trust Nasdaq Pharmaceuticals ETF ExpensesTypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.60%0.56%0.54%0.49%0.52%Other Expenses0.00%0.33%0.49%0.41%0.54%Total Expense0.60%0.71%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.53%-0.33%-0.58%Net Expense0.60%0.61%0.61%0.56%0.59% First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & ExposureTop 10 FTXH HoldingsAbbVie(NYSE:ABBV)Holding Weight: 7.57%Pfizer(NYSE:PFE)Holding Weight: 7.35%Johnson & Johnson(NYSE:JNJ)Holding Weight: 6.88%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 6.41%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 6.17%United Therapeutics(NASDAQ:UTHR)Holding Weight: 4.70%Eli Lilly and Company(NYSE:LLY)Holding Weight: 4.26%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 4.19%Amgen(NASDAQ:AMGN)Holding Weight: 4.03%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 3.86%FTXH Sector ExposureFTXH Industry ExposureFull Holdings Details Similar ETFsHorizon Kinetics Medical ETFNASDAQ:MEDXJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipWMG Financial Advisors LLCSold 2,153 shares on 7/30/2024Ownership: 2.059%International Assets Investment Management LLCBought 2,662 shares on 7/30/2024Ownership: 0.410%View All Institutional Transactions FTXH ETF - Frequently Asked Questions How have FTXH shares performed this year? First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 on January 1st, 2024. Since then, FTXH shares have increased by 7.6% and is now trading at $28.65. View the best growth stocks for 2024 here. Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders? First Trust Nasdaq Pharmaceuticals ETF's top institutional shareholders include WMG Financial Advisors LLC (2.06%) and International Assets Investment Management LLC (0.41%). How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF? Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC) and BioCorRx (BICX). This page (NASDAQ:FTXH) was last updated on 9/12/2024 by MarketBeat.com Staff From Our Partners⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | SponsoredTesla of the Skies?Remember when Tesla disrupted the auto industry? Buckle up, because they could have the potential to do the sa...Market JAR | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
